Sign In
Buy OMI
$2.80
+0 (+0%)
At Close: Mar 30, 2026
Is GN Store Nord (GNNDY) a Great Value Stock Right Now?
01:40pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Boston Scientific (BSX) Q1 Earnings Top, 2022 Revenue View Up
03:37pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Boston Scientific (BSX) registers a year-over-year improvement in organic sales, indicating a strong rebound in the legacy business from the pandemic mayhem.
Chemed's (CHE) Q1 Earnings Top Estimates, Margins Increase
03:01pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
In Q1, Chemed's (CHE) VITAS revenue decline was primarily the result of a 4.1% decline in days of care.
Earnings Preview: Owens & Minor (OMI) Q1 Earnings Expected to Decline
07:01pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Philips' (PHG) Q1 Earnings Down Y/Y on Supply Chain Constraints
04:25pm, Monday, 25'th Apr 2022 Zacks Investment Research
Koninklijke Philips' (PHG) Q1 top- and bottom-line results reflect negative impact of supply chain constraints and consequences of the Respironics field action.
Here's Why You Should Retain Integra (IART) Stock For Now
03:12pm, Friday, 22'nd Apr 2022 Zacks Investment Research
Investors are optimistic about Integra (IART), given the strength in its CSS arm and notable product launches.
Owens & Minor will Report First Quarter 2022 Financial Results on Tuesday, May 3, 2022
07:05am, Thursday, 21'st Apr 2022
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the first quarter of 2022 after market close on Tuesday, May 3, 2022. The Company will host a con
Here's Why You Should Hold on to Illumina (ILMN) Stock For Now
02:13pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Investors are optimistic about Illumina's (ILMN) strategic collaborations and strong international sales.
Patterson Companies (PDCO) Moves Up 12.5%: What's Driving It?
02:17pm, Tuesday, 19'th Apr 2022 Zacks Investment Research
Investors are optimistic about Patterson Companies' (PDCO) robust segmental performance and strong prospects in the dental space.
Here's Why You Should Retain Zimmer Biomet (ZBH) Stock For Now
01:31pm, Monday, 18'th Apr 2022 Zacks Investment Research
Investors are optimistic about Zimmer Biomet (ZBH) given robust demand for its ROSA robotics line and continued investment in profitable business areas.
Here's Why You Should Hold on to Haemonetics (HAE) For Now
02:29pm, Thursday, 14'th Apr 2022 Zacks Investment Research
Investors are optimistic about Haemonetics (HAE) given the strength in its Hemostasis Management franchise and increased product uptake.
Has Owens & Minor (OMI) Outpaced Other Medical Stocks This Year?
01:40pm, Thursday, 14'th Apr 2022 Zacks Investment Research
Here is how Owens & Minor (OMI) and Patterson Cos. (PDCO) have performed compared to their sector so far this year.
Illumina (ILMN) Hurt by Rising Costs, Tough Competition
12:44pm, Thursday, 14'th Apr 2022 Zacks Investment Research
Regulatory complications are raising the legal expenses for Illumina (ILMN), thereby building pressure on the bottom line.
Has Owens & Minor (OMI) Outpaced Other Medical Stocks This Year?
11:18am, Thursday, 14'th Apr 2022
Here is how Owens & Minor (OMI) and Patterson Cos. (PDCO) have performed compared to their sector so far this year.
NEOGEN (NEOG) Adds to Prozap Insect Control Product Line-up
02:09pm, Wednesday, 13'th Apr 2022 Zacks Investment Research
NEOGEN's (NEOG) latest Prozap Protectus Pour-On Insecticide- IGR product relieves cattle from infestations.
